541 related articles for article (PubMed ID: 16399845)
1. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
[TBL] [Abstract][Full Text] [Related]
2. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients.
Arranz O; Ara J; Rodriguez R; Quintó L; Font J; Mirapeix E; Darnell A
Clin Nephrol; 2001 Oct; 56(4):295-301. PubMed ID: 11680659
[TBL] [Abstract][Full Text] [Related]
4. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
[TBL] [Abstract][Full Text] [Related]
7. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
8. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
9. Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis.
Rarok AA; Huitema MG; van der Leij MJ; van der Geld YM; Berthold H; Schmitt J; Stegeman CA; Limburg PC; Kallenberg CG
Am J Clin Pathol; 2003 Oct; 120(4):586-95. PubMed ID: 14560570
[TBL] [Abstract][Full Text] [Related]
10. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
12. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
13. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.
Damoiseaux J; Vaessen M; Knapen Y; Csernok E; Stegeman CA; Van Paassen P; Tervaert JW
Ann N Y Acad Sci; 2007 Aug; 1109():454-63. PubMed ID: 17785334
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Ann Rheum Dis; 2006 Nov; 65(11):1484-9. PubMed ID: 16504995
[TBL] [Abstract][Full Text] [Related]
17. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.
Choi HK; Lamprecht P; Niles JL; Gross WL; Merkel PA
Arthritis Rheum; 2000 Jan; 43(1):226-31. PubMed ID: 10643719
[TBL] [Abstract][Full Text] [Related]
18. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
19. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
[TBL] [Abstract][Full Text] [Related]
20. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
